1 month ago
DNA Methylation Unlocks New Pathways for Brain Repair by Reprogramming Astrocytes
Recent research from scientists in Germany has uncovered a critical mechanism by which astrocytes, a type of brain cell, can transform into neural stem cells, DNA methylation revealing new avenues for brain repair.
Read full news: https://thelifesciencesmag...
#BrainRepair #DNAMethylation #AstrocyteReprogramming #Neurogenesis #StemCellResearch #NeuralRegeneration #epigenetics #BrainInjuryHealing #DNMT3A #FutureOfTherapies
Recent research from scientists in Germany has uncovered a critical mechanism by which astrocytes, a type of brain cell, can transform into neural stem cells, DNA methylation revealing new avenues for brain repair.
Read full news: https://thelifesciencesmag...
#BrainRepair #DNAMethylation #AstrocyteReprogramming #Neurogenesis #StemCellResearch #NeuralRegeneration #epigenetics #BrainInjuryHealing #DNMT3A #FutureOfTherapies
DNA Methylation Reprograms Astrocytes For Brain Repair | The Lifesciences Magazine
Recent research from scientists in Germany has uncovered a critical mechanism by which astrocytes, a type of brain cell, can transform into neural stem cells, DNA methylation revealing new avenues for brain repair.
https://thelifesciencesmagazine.com/dna-methylation-reprograms-astrocytes/
5 months ago
Stem Cells Industry Data Book - Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030
Download Sample Copy@ https://tinyurl.com/2ufp9k...
The stem cells industry data book is a combination of the market data from five reports namely, the stem cells market, human embryonic stem cells market, induced pluripotent stem cells production market, mesenchymal stem cells market, and cancer stem cells market. The stem cells market was valued at USD 13.26 Billion in 2022 with a CAGR of 11.4% during 2023-2030. The induced pluripotent stem cells production market was valued at USD 1.36 Billion in 2022 with a CAGR of 9.3% during 2023-2030. The human embryonic stem cells market was valued at USD 1.10 Billion in 2022 with a CAGR of 10.6% during 2023-2030. The mesenchymal stem cells market was valued at USD 3.02 Billion in 2022 with a CAGR of 11.4% during 2023-2030. Cancer stem cells market was valued at USD 2.59 Billion in 2022 with a CAGR of 12.1% during 2023-2030.
The stem cell market is anticipated to be driven primarily by the expanding development of precision medicine, growth in the number of cell therapy production facilities, and expansion in the number of clinical trials. Recent developments in tissue engineering and stem cell therapy have the potential to attract attention for the treatment of a number of chronic diseases. Additionally, increasing research activities into the synthesis, storage, and characterization of stem cells as well as rising demand for stem cell banking are anticipated to support the market's revenue growth.
#StemCellBreakthroughs #RegenerativeMedicine2030 #MedicalInnovation2023 #FutureOfHealthcare #StemCellTherapies #AdvancingMedicine #RegenerationRevolution #HealthcareTransformation #CellularTherapies #StemCellResearch
Download Sample Copy@ https://tinyurl.com/2ufp9k...
The stem cells industry data book is a combination of the market data from five reports namely, the stem cells market, human embryonic stem cells market, induced pluripotent stem cells production market, mesenchymal stem cells market, and cancer stem cells market. The stem cells market was valued at USD 13.26 Billion in 2022 with a CAGR of 11.4% during 2023-2030. The induced pluripotent stem cells production market was valued at USD 1.36 Billion in 2022 with a CAGR of 9.3% during 2023-2030. The human embryonic stem cells market was valued at USD 1.10 Billion in 2022 with a CAGR of 10.6% during 2023-2030. The mesenchymal stem cells market was valued at USD 3.02 Billion in 2022 with a CAGR of 11.4% during 2023-2030. Cancer stem cells market was valued at USD 2.59 Billion in 2022 with a CAGR of 12.1% during 2023-2030.
The stem cell market is anticipated to be driven primarily by the expanding development of precision medicine, growth in the number of cell therapy production facilities, and expansion in the number of clinical trials. Recent developments in tissue engineering and stem cell therapy have the potential to attract attention for the treatment of a number of chronic diseases. Additionally, increasing research activities into the synthesis, storage, and characterization of stem cells as well as rising demand for stem cell banking are anticipated to support the market's revenue growth.
#StemCellBreakthroughs #RegenerativeMedicine2030 #MedicalInnovation2023 #FutureOfHealthcare #StemCellTherapies #AdvancingMedicine #RegenerationRevolution #HealthcareTransformation #CellularTherapies #StemCellResearch
